Attenuation of sepsis-induced rat liver injury by epigallocatechin gallate via suppression of oxidative stress-related inflammation by Yang, Jian-xin et al.
Yang et al 
2877 
 
Tropical Journal of Pharmaceutical Research December 2017; 16 (12): 2877-2884 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v16i12.11 
Original Research Article 
 
 
Attenuation of sepsis-induced rat liver injury by 
epigallocatechin gallate via suppression of oxidative 
stress-related inflammation 
 
Jian-xin Yang1, Yu-lin Li1*, Ning-chuan Shi2 
1Department of Emergency, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 
310009, 2College of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China 
 
*For correspondence: Email: 2513003@zju.edu.cn 
 
Sent for review: 30 August 2017        Revised accepted: 29 November 2017 
 
Abstract 
Purpose: To evaluate the effect of epigallocatechin gallate (EGCG) on sepsis-induced liver injury in a 
rat model of sepsis established by cercal ligation and puncture (CLP). 
Methods: Male Wistar rats were randomly divided into 6 groups (n = 12): normal control, sepsis, 
dexamethasone (5 mg/kg), low-dose EGCG (12.5 mg/kg), medium-dose EGCG (25 mg/kg), and high-
dose EGCG (50 mg/kg) groups. Dexamethasone and EGCG were given once daily. Survival rates 
following CLP were recorded. Serum alanine aminotransferase (ALT) and aspartate aminotransferase 
(AST) levels were measured to evaluate liver function. Tumor necrosis factor-α (TNF-α) and interleukin 
(IL)-10 were determined by ELISA. Superoxide dismutase (SOD) and levels of glutathione (GSH) and 
malondialdehyde (MDA) were assayed to evaluate oxidative stress. Protein and mRNA expression 
levels of heme oxygenase-1 (HO-1) and nuclear factor erythroid 2-related factor (Nrf2) were measured 
by Western blotting and quantitative real-time polymerase chain reaction (qRT-PCR), respectively.  
Results: Survival rates were significantly (p < 0.05) increased by EGCG (83.3 %) when compared to 
the untreated sepsis group (33.3 %) or dexamethasone-treated sepsis group (41.7 %). The increase in 
survival rates was associated with significant decreases in AST, ALT, MDA, and TNF-α, and significant 
elevations in SOD, GSH, and IL-10. QRT-PCR and Western blotting data indicate that there was 
increase in hepatic expression of Nrf-2 and HO-1 of EGCG-treated sepsis rats, relative to the untreated 
sepsis group.  
Conclusion: These results suggest that EGCG treatment reduces sepsis-induced liver injury and 
improves the survival rate of rats with polymicrobial sepsis by reducing oxidative stress via regulation of 
Nrf2/HO-1 signaling. These findings highlight the promising potential of EGCG for the treatment of 
sepsis. 
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 Sepsis is often the main cause of death in a 
surgical intensive care unit (ICU), and is still a 
worldwide challenge [1]. Multiple pro-
inflammatory cytokines (including TNF-α are 
accumulated during sepsis and are involved in 
the pathogenesis of sepsis [2].  
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Systemic inflammation could lead to multiple 
organ injury, including liver injury. Liver injury in 
sepsis progresses from active hepatocellular 
dysfunction to liver damage and finally to liver 
failure [3]. The liver performs a wide range of 
biological functions in metabolic and 
immunological homeostasis, and contributes to 
bacterial clearance in sepsis [4]. It has been 
demonstrated that liver failure is significantly 
associated with poor prognosis in critically ill 
sepsis patients [5]. 
 
Oxidative stress occurs when the rate of reactive 
species generation exceeds the antioxidant 
capacity, resulting in excessive oxidants in cells 
[6]. Accumulating evidence demonstrate that 
severe oxidative stress is present in patients with 
sepsis, due to overload of reactive oxygen 
species (ROS) and inadequate anti-oxidative 
defenses [7]. Oxidative stress is involved in the 
pathology of sepsis through several different 
mechanisms, and it is highly associated with 
inflammation [8]. Oxidative stress directly attacks 
endothelial cells and affects oxygen 
consumption, thus promoting organ failure [9]. 
Therefore, in sepsis situations, it is important to 
overcome oxidative stress and the resulting 
disease progression using antioxidants.  
 
Green tea contains four major polyphenols, of 
which EGCG is the most active antioxidant 
component [10]. In the present study, the 
protective role of EGCG against oxidative stress 
and liver injury in rats subjected to CLP-induced 




Animals and reagents 
 
Adult male Wistar rats (mean body weight = 250 
± 10 g) were housed three per metabolic cage 
under a 12 h light-12 h dark cycle. All rats were 
maintained for seven days to observe their health 
condition before the experiment. All the animal 
experiments were approved by the Animal Care 
and Use Committee of the Second Affiliated 
Hospital of Zhejiang University School of 
Medicine (ref no. 2016-13), and were in 
accordance with Principles of Laboratory Animal 
Care (NIH publication no. 85-23, revised 1985) 
[11]. Dexamethasone and EGCG were obtained 
from Sigma (St. Louis, USA).  
 
The adult male Wistar rats were divided into six 
groups (n = 12 in each group): normal control 
group, sepsis group (septic rats without 
treatment), dexamethasone group (septic rats 
treated with 5 mg/kg dexamethasone), low-dose 
EGCG group (septic rats treated with 12.5 mg/kg 
EGCG), medium-dose EGCG group (septic rats 
treated with 25 mg/kg EGCG), and high-dose 
EGCG group (septic rats treated with 50 mg/kg 
EGCG). Dexamethasone and EGCG were 
administered as appropriate, in saline once daily 




Cecal ligation and puncture (CLP) was 
performed as described previously, but with 
slight modifications [12]. Pentobarbital (30 
mg/kg) was administered intraperitoneally to 
anesthetize the rats. Using sterile techniques, a 
3-cm long incision was made along the midline of 
the abdomen to allow exposure of the cecum 
with the adjoining intestine. The cecum was 
ligated with no bowel obstruction and punctured 
once with an 18-gauge needle. The cecum was 
then gently squeezed to leak some fecal 
material, after which the cecum was returned to 
the abdominal cavity. In normal control rats, 
cecum was moved but was not ligated or 
punctured. Finally, the abdominal incision was 
closed under sterile conditions. After the 
operations, all rats were given 3 mL/100 g body 
weight of saline solution and antibiotic therapy. 
All animals were maintained under the same 




Animals were sacrificed at 6, 12 and 24 h 
following the surgery. Blood samples and liver 
tissues were also obtained from rats with CLP 
and normal control rats. After standing, the 
serum was separated by centrifugation and 
frozen at −80 °C until analysis. Liver tissues were 
rapidly removed and frozen at −80 °C until 
subsequent analysis. 
 
Determination of hepatic marker enzymes 
 
Serum ALT and AST levels were evaluated using 
commercially available diagnostic kits (Sigma, St. 
Louis, USA). 
 
Measurement of oxidative stress parameters 
 
Liver tissue samples were collected at different 
time-points after CLP, and homogenized 
separately. The level of MDA in the tissue 
homogenate was measured according to the 
method of Ohkawa [13]. Determination of GSH 
was performed according to the method of 
Ellman [14]. The SOD activity in the liver tissue 
was measured using the method described 
previously [15]. 
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Enzyme-linked immunosorbent assay (ELISA) 
 
Levels of TNF-α and IL-10 were assayed using 
appropriate commercial kits (Abcam, Cambridge, 
UK) in line with the manufacturer’s instructions. 
 
Quantitative real-time polymerase chain 
reaction  
 
TRIzol was used to extract total RNA from rat 
livers. The extracted total RNA was reverse-
transcribed with Quantitate Reverse 
Transcription Kit (Qiagen,Hilden, Germany). 
Quantitative real-time PCR was performed using 
SYBR green mix (TOYOBO, Osaka, Japan) on 
Bio-Rad Real-time PCR platform. The following 
primer sequences were used: 
 
5’-GCTATTTTCCATTCCCGAGTTAC-3’and 5’-
ATTGCTGTCCATCTCTGTCAG-3’ (for rat Nrf2); 
5’-CTTTCAGAAGGGTCAGGTGTC-3’ and 5’-
TGCTTGTTTCGCTCTATCTCC-3’ (for rat HO-1); 
and 5’-GTATTGGGCGCCTGGTCACC-3’ and 5’-
CGCTCCTGGAAGATGGTGATGG-3’ (for rat 
GAPDH). 
 
Western blot analysis 
 
Western blotting was performed as previously 
reported [16] using mouse anti-rat Nrf2 (1/1000) 
monoclonal antibody (Abcam, Cambridge, UK), 
mouse anti-rat HO-1 (1/5000) monoclonal 
antibody (Abcam, Cambridge, UK) and mouse 
anti-rat GAPDH (1/5000) monoclonal antibody 
(Abcam, Cambridge, UK). This was followed by 
secondary peroxidase-conjugated antibody 
(1/2000) (Zhongshan Golden Bridge 
Biotechnology, Beijing, China). The immuno-
complexes were visualized using enhanced 





The results are presented as mean ± standard 
deviation (SD) and were analyzed using Mann-
Whitney U test. Statistical significance was 
calculated by Prism 5 software (GraphPad). P < 




EGCG treatment improved survival after CLP-
induced sepsis. 
 
The survival of the rats at different time-points 
following surgery are shown in Figure 1. Survival 
of normal control rats was 100 % (12/12), 
whereas the survival of untreated septic rats 
decreased to 33.3 % (4/12) at 72 h after CLP. 
Dexamethasone treatment had no significant 
effects on survival rate when compared with 
untreated rats after CLP (p > 0.05). However, the 
survival rates of high dose EGCG-treated septic 
rats were significantly higher than that of the 
untreated sepsis group and the dexamethasone 
group (p < 0.05). 
 
EGCG protected the rats against sepsis-
induced liver injury  
 
Next, the effects of EGCG treatment on liver 
injury caused by sepsis were evaluated. Serum 
samples were collected separately at 6, 12 and 
24 h following CLP and used to analyze liver 
function. It was found that sepsis caused severe 
liver injury as reflected in increased serum levels 
of ALT and AST at 6 h (p < 0.05); and at 12 and 
24 h after CLP-induced sepsis (p < 0.01; Figure 
2). Treatment with EGCG, especially high dose 
EGCG, but not dexamethasone, significantly (p < 
0.05) decreased serum levels of ALT (Figure 2A) 
and AST (Figure 2B) after CLP-induced sepsis. 
 
Figure 1: Comparison of the survival rates at 0, 6, 12, 18, 24, 36, 48 and 72 h among the six experimental 
groups after CLP. Data are expressed as percentages 
 




Figure 2: Effect of EGCG on sepsis-induced liver function alterations. ALT levels (A) and AST levels (B) in serum 
were quantified. Data are presented as mean ± SD, n = 5. #p < 0.05, when compared with untreated sepsis 
group; *p < 0.05, when compared with normal control group; **p < 0.01, when compared with normal control 
group 
 
EGCG treatment attenuated oxidative stress 
during sepsis  
 
The next step was to analyze some oxidative 
stress parameters in the liver tissues. The levels 
of intrahepatic MDA in septic rats were 
significantly higher after CLP than corresponding 
values in normal control rats at 6 h (p < 0.05), 12 
h (p < 0.01), and 24 h (p < 0.01). The EGCG 
treatment, however, effectively down-regulated 
the MDA levels (especially high dose EGCG 
treatment (p < 0.05) after CLP, when compared 
with untreated sepsis group (Figure 3A). Data 
from antioxidants analysis showed that the 
intrahepatic SOD activity and GSH levels were 
highest in the normal control group, but 
significantly lower in the untreated sepsis group 
and dexamethasone-treated sepsis group (p < 
0.05 or p < 0.01). However, intrahepatic SOD 
activity and GSH levels increased significantly 
after treatment with high dose EGCG (p < 0.05). 
The effects of EGCG on these oxidative stress 
parameters in the liver were dose-dependent. 
 
EGCG inhibited inflammation due to CLP-
induced sepsis 
 
To test whether EGCG treatment might mitigate 
inflammation after CLP-induced sepsis, serum 
levels of TNF-α and IL-10 were assayed. The 
level of the pro-inflammatory mediator TNF-α 
was higher in untreated sepsis group than in the 
normal control group (p < 0.05), whereas the 
anti-inflammatory mediator IL-10 was lower in 
untreated sepsis group than in the normal control 
group (p < 0.05). Furthermore, high dose EGCG 
treatment significantly inhibited the CLP-induced 
inflammation as indicated by decreased 
production of TNF-α (p < 0.01) and increased 
production of IL-10 (p < 0.01) at 12 and 24 h 
following CLP (Table 1). 
 
EGCG treatment up-regulate the expression 
of antioxidant genes  
 
Intrahepatic Nrf2 and HO-1 expressions as 
reflected by mRNA and protein levels were 
decreased significantly (p < 0.01) in septic rats 
when compared with normal control rats. 
However, their expressions were significantly (p 
< 0.05) increased after high dose EGCG 




Rat models of CLP-induced sepsis provide useful 
tools for testing the effect of potential therapeutic 
agents [17]. Results obtained in the present 
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study showed that the plant polyphenol EGCG 
extracted from Green Tea modulated 
inflammation, attenuated liver injury and 
improved survival rate in the CLP-induced sepsis 
rat model through its anti-oxidant effect. 
 
Previous studies have revealed that liver injury 
was accompanied by sepsis since increased 
levels of hepatic enzymes (ALT and AST) which 
are indicators of impaired hepatic membranes, 
were always seen during sepsis [18]. Increased 
serum ALT and AST levels were consistently 
observed in the CLP-induced septic rats in this 
study. EGCG treatment at 2 h after CLP resulted 
in decreased serum ALT and AST levels, 
indicating its ability to protect liver functional 
integrity against sepsis. It would be interesting to 
carry out further studies on the protective effect 
of EGCG against other organ injuries during 
sepsis and other inflammatory diseases. 
 
 
Figure 3: Effect of EGCG on oxidative stress in septic rats. Liver tissue samples were taken at indicated time-
points for measurement of MDA (A), SOD (B) and GSH (C). Data are presented as mean ± SD, n = 5; #p < 0.05, 
when compared with untreated sepsis group; *p < 0.05, when compared with normal control group; **p < 0.01, 
when compared with normal control group 
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Table 1: Serum levels of TNF-α and IL-10 in normal control and septic rats at indicated time-points 
 
Variable Control Sepsis Hexadecadrol EGCG Low EGCG Middle EGCG High 
6h 
TNF-α 
(ng/ml) 44.9±9.9 48.4±7.5* 46.1±6.8 45.3±7.7 49.5±5.8 47.9±8.8 
IL-10 
(ng/ml) 146.9±18.8 122.8±13.2** 121.1±15.5 126.9±9.9 121.4±10.2 122.3±15.5 
12h 
TNF-α 
(ng/ml) 45.7±5.8 53.7.9±10.1** 54.9±9.11 51.7±6.12 49.6.9±9.13## 47.9±8.14## 
IL-10 
(ng/ml) 155.1±9.8 126.8±13.2** 127.1±15.5 129.9±5.5 131.4±13.3# 138.2 ±11.1## 
24h 
TNF-α 
(ng/ml) 43.1±4.8 102.3±7.7** 99.9±9.1 80.9±6.8## 76.6±7.5## 69.9±8.3## 
IL-10 
(ng/ml) 153.1±10.3 125.2±9.4** 121.1±13.8 129.9±9.9 133.4±11.2# 141.1±13.7## 
Values are mean ± SD; *p < 0.05, when compared with normal control group; **p < 0.01, when compared with 
normal control group. #p < 0.05, when compared with untreated sepsis group; ##p < 0.01, when compared with 
untreated sepsis group 
 
 
Figure 4: Expression levels of Nrf2 and HO-1 in liver tissues showing mRNA expressions of Nrf2 (A) and HO-1 
(B. Nrf2 (C) and HO-1 (D). Data are presented as mean ± SD, n = 4. **p < 0.01, when compared with normal 
control group; #p < 0.05, when compared with untreated sepsis group; ##p < 0.01, when compared with 
untreated sepsis group 
 
Systematic inflammation response is considered 
a hallmark of sepsis. Among the numerous pro- 
and anti-inflammatory cytokines studied during 
sepsis, TNF-α and IL-10 are of crucial 
importance [19]. In this study, it was 
demonstrated that EGCG treatment relieved the 
inflammation during sepsis. This was 
demonstrated by the observed significant 
decrease in TNF-α, and significant increase in IL-
10 levels at different time-points after CLP. 
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These results suggest that EGCG may be a 
potential therapeutic approach to sepsis. 
 
Previous investigations have established that 
oxidative stress, which is the consequence of 
imbalance between the levels of cellular oxidants 
and antioxidants, participates in the 
pathogenesis of sepsis [9]. Besides, several 
studies have shown the effect of anti-oxidant 
drugs on improvement of survival during sepsis 
[20-22].  
 
Polyphenols are secondary metabolites seen 
largely in plants. They have attracted much 
attention for their potential health benefits 
because of their antioxidant properties and safety 
[23]. EGCG is the major catechin in green tea 
and is considered an antioxidant which prevents 
oxidative stress. In animal models, EGCG 
exhibits protective roles in varied pathological 
conditions, including Parkinson’s disease and 
diabetes [23-25].  
 
In the present study, it has been shown that 
EGCG reduced sepsis-induced oxidative stress 
through its effect on the levels of hepatic 
oxidative stress parameters such as SOD and 
GSH. Furthermore, EGCG promoted the 
expressions of hepatic Nrf2 and HO-1, indicating 
the implication of Nrf2/HO-1 signaling pathway in 




The results of this study suggest that EGCG has 
a potential for use as a treatment strategy for 
sepsis and sepsis-induced liver injury as 
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